EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1 Reporter for Stable Red Fluorescence

Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA encoding mCherry, a monomeric red fluorescent protein derived from Discosoma DsRed. The mRNA integrates a Cap 1 structure enzymatically capped using Vaccinia virus capping enzymes, which closely mimics mammalian mRNA and enhances translation efficiency (EZ Cap™ mCherry mRNA datasheet). Incorporation of 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) suppresses RNA-mediated innate immune responses and increases mRNA stability (Guri-Lamce et al., 2024). The mRNA is 996 nucleotides long, supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, and includes a poly(A) tail for further translation enhancement. This R1017 kit is optimized for fluorescent reporter assays and molecular localization studies in cell biology.

Biological Rationale

Reporter gene mRNAs are essential for visualizing and quantifying gene expression and cell localization within living systems (mCherry mRNA with Cap 1 Structure: Advancing Reporter Gen). The red fluorescent protein mCherry, encoded by this mRNA, is a monomeric variant of DsRed with excitation/emission maxima at ~587/610 nm (FPbase mCherry). Cap 1 mRNA capping closely replicates endogenous eukaryotic mRNAs, improving translation efficiency and reducing innate immune recognition by host cells. Modified nucleotides such as 5mCTP and ψUTP are integrated to avoid immune activation and prolong mRNA stability, critical for in vitro and in vivo applications (Guri-Lamce et al., 2024).

Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

The mCherry mRNA is synthesized via in vitro transcription and incorporates two key modifications:

• Cap 1 Structure: The 5’ end of the mRNA is enzymatically capped using Vaccinia virus capping enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2′-O-methyltransferase. This Cap 1 structure increases translation efficiency and accurately mimics mammalian mRNA capping, reducing detection by innate immune sensors (Redefining Reporter Gene mRNA).
• Modified Nucleotides: The integration of 5mCTP (5-methylcytidine triphosphate) and ψUTP (pseudouridine triphosphate) into the mRNA backbone suppresses Toll-like receptor-mediated immune responses and increases mRNA half-life (Guri-Lamce et al., 2024).
• Poly(A) Tail: A polyadenylated tail is appended to the 3’ end to enhance translation initiation and mRNA stability.

Upon delivery into cells (commonly via lipid nanoparticles or transfection reagents), the mRNA is translated by ribosomes into mCherry, which emits red fluorescence. The modifications collectively increase protein yield and duration of signal in reporter assays.

Evidence & Benchmarks

• Lipid nanoparticles efficiently deliver modified mRNAs (including those with Cap 1 and nucleotide modifications) for robust protein expression in human fibroblasts (Guri-Lamce et al., 2024).
• 5mCTP and ψUTP modifications suppress innate immune activation and prolong mRNA stability in vitro and in vivo (Guri-Lamce et al., 2024).
• Cap 1-structured mRNAs show significantly higher translational efficiency compared to uncapped or Cap 0 mRNAs (Next-Generation Reporter Genes: Mechanistic Innovations).
• mCherry encoded by reporter mRNA is monomeric, 236 amino acids, with a molecular weight of ~26.7 kDa and emits at 610 nm when excited at 587 nm (FPbase).
• EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is stable at or below -40°C for long-term storage, maintaining activity in sodium citrate buffer, pH 6.4 (Product page).

This article updates Next-Generation mCherry mRNA Reporters by providing a current synthesis of mRNA modifications and Cap 1 capping data, with new benchmarks from 2024 LNP delivery research.

Applications, Limits & Misconceptions

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is intended for use as a reporter gene in molecular and cell biology research.

• Fluorescent tracking: Enables direct visualization of cell populations, subcellular targeting, and protein localization.
• Transfection optimization: The Cap 1 and nucleotide modifications allow for higher expression and reduced cytotoxicity in sensitive cell types.
• Compatibility: Suitable for use in a wide range of mammalian cells, including primary and stem cells, and compatible with LNP-based delivery (Guri-Lamce et al., 2024).

See Redesigning Reporter Gene Strategies for a broader discussion of clinical and diagnostic contexts, which this article clarifies by focusing on fundamental workflow integration and benchmarking.

Common Pitfalls or Misconceptions

• Not a genomic integration tool: This mRNA does not integrate into the host genome, so expression is transient.
• Storage dependency: Stability and activity rapidly decline if stored above -40°C or outside sodium citrate buffer, pH 6.4.
• Immune evasion is not absolute: While 5mCTP/ψUTP reduce immune activation, some cell types may still recognize foreign mRNA.
• Not suitable for in vivo therapeutic use without further formulation: The product is intended for research, not clinical therapy.
• Fluorescence is excitation-dependent: mCherry fluorescence requires excitation at ~587 nm and correct filter settings (emission at ~610 nm).

Workflow Integration & Parameters

For optimal results with the R1017 kit, the following parameters are recommended:

• Store at ≤ -40°C in 1 mM sodium citrate, pH 6.4.
• Thaw on ice before use and avoid repeated freeze-thaw cycles.
• Deliver mRNA using optimized lipid nanoparticle formulations or transfection reagents, such as Lipofectamine MessengerMAX (see Guri-Lamce et al., 2024).
• Typical working mRNA concentrations range from 10 ng/µL to 1 µg/µL, depending on cell type and transfection method.
• Monitor fluorescence using excitation at 587 nm and emission detection at 610 nm.

Conclusion & Outlook

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) advances the field of fluorescent reporter assays by integrating Cap 1 capping and immune-evasive nucleotide modifications. These features enable robust, stable, and low-immunogenicity expression of mCherry for molecular tracking and cell localization workflows. The product sets a high standard for next-generation reporter gene tools in research pipelines. For further insight into competitive positioning and advanced delivery strategies, see Next-Generation Reporter Genes: Mechanistic Innovations, which this article extends by providing updated, peer-reviewed evidence and practical workflow guidance. For full specifications, visit the EZ Cap™ mCherry mRNA (5mCTP, ψUTP) product page.